News | February 20, 2021
Zydus Cadila receives final approval from USFDA for Droxidopa capsules
It is used to treat low blood pressure that causes severe dizziness or a lightheaded feeling.
It is used to treat low blood pressure that causes severe dizziness or a lightheaded feeling.
Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, are indicated for the treatment of orthostatic dizziness
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta
Medico Remedies receives order worth US$ 1,781,000
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
For the full financial year FY25, revenue from operations grew 9 per cent to Rs. 11,537.8 crore, compared to Rs. 10,588 crore in FY24.
Tatva Chintan Pharma Chem receives export order worth $35, 55,000
Subscribe To Our Newsletter & Stay Updated
